Literature DB >> 30290997

Relation between adenoid size and otitis media with effusion.

L Skoloudik1, D Kalfert2, T Valenta1, V Chrobok1.   

Abstract

AIMS: This study compares the efficacy of adenoidectomy on otitis media with effusion (OME) in patients with different size of adenoids and the connection between differently sized adenoids and middle ear effusion.
MATERIAL AND METHODS: Children with a history of at least 3 months' OME underwent adenoidectomy and myringotomy without the insertion of a tympanostomy tube. Treatment assignment was stratified by adenoids' size causing choanal obstruction (grade I-III) and according to Eustachian tube ostium obstruction (grade A-C). The subjects were followed for 12 months.
RESULTS: Adenoidectomy was significantly more effective in children with adenoids in contact with torus tubarius (grade B, C) compared to those with small adenoids without contact (P<0.001). The volume of the adenoids was irrelevant (P=0.146). The size of adenoids did not affect the viscosity of the middle ear secretion. The distribution of mucous and serous secretion was not dependent on the size of adenoids; the efficacy of adenoidectomy was 82% in mucous as well as serous secretion.
CONCLUSION: The relation between adenoids and torus tubarius is more important than the volume of the adenoids. The viscosity of middle ear fluids (serous or mucous) did not influence the rate of treatment efficacy.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Adenoid size; Adenoidectomy; Myringotomy; Otitis media with effusion

Mesh:

Year:  2018        PMID: 30290997     DOI: 10.1016/j.anorl.2017.11.011

Source DB:  PubMed          Journal:  Eur Ann Otorhinolaryngol Head Neck Dis        ISSN: 1879-7296            Impact factor:   2.080


  8 in total

1.  Effects of Adenoidectomy and Adenotonsillectomy on Tympanostomy Tube Reinsertion Based on Korean Population-Based National Sample Cohort Data.

Authors:  Junhui Jeong; Hyunsun Lim; Tae Seong Eo; Kyuin Lee; Jangwon Oh; Hyun Seung Choi
Journal:  J Int Adv Otol       Date:  2020-12       Impact factor: 1.017

2.  Letter to the editor regarding article: "Modified adenoid grading system for evaluating adenoid size in children: a prospective validation study".

Authors:  Xiangming Meng
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-06-01       Impact factor: 3.236

3.  Comment on Zwierz et al. The Long-Term Effects of 12-Week Intranasal Steroid Therapy on Adenoid Size, Its Mucus Coverage and Otitis Media with Effusion: A Cohort Study in Preschool Children. J. Clin. Med. 2022, 11, 507.

Authors:  David Kalfert
Journal:  J Clin Med       Date:  2022-04-02       Impact factor: 4.241

Review 4.  ADENOID SIZE IN CHILDREN WITH OTITIS MEDIA WITH EFFUSION.

Authors:  Marta Zrinka Galić; Marisa Klančnik
Journal:  Acta Clin Croat       Date:  2022-02       Impact factor: 0.780

5.  Reply to Kalfert, D. Comment on "Zwierz et al. The Long-Term Effects of 12-Week Intranasal Steroid Therapy on Adenoid Size, Its Mucus Coverage and Otitis Media with Effusion: A Cohort Study in Preschool Children. J. Clin. Med. 2022, 11, 507".

Authors:  Aleksander Zwierz
Journal:  J Clin Med       Date:  2022-04-19       Impact factor: 4.241

6.  Risk factors and antibiotic sensitivity of aerobic bacteria in Chinese children with adenoid hypertrophy.

Authors:  Lujie Zuo; Li He; Aiping Huang; Yingying Liu; Aiying Zhang; Li Wang; Yingluan Song; Jiangqiao Geng
Journal:  BMC Pediatr       Date:  2022-09-19       Impact factor: 2.567

7.  The Formation of Biofilm and Bacteriology in Otitis Media with Effusion in Children: A Prospective Cross-Sectional Study.

Authors:  Artur Niedzielski; Lechosław Paweł Chmielik; Tomasz Stankiewicz
Journal:  Int J Environ Res Public Health       Date:  2021-03-30       Impact factor: 3.390

8.  Tympanoplasty and adenoidectomy in children: Comparison of simultaneous and sequential approaches.

Authors:  Timur Shamshudinov; Laura Kassym; Saule Taukeleva; Bolat Sadykov; Hassan Diab; Mario Milkov
Journal:  PLoS One       Date:  2022-03-10       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.